Hints and tips:
Related Special Reports
...Leasing costs tied to Metro’s network of 76 branches were also unappealing for HSBC, said one of the people....
...He sold out in 2020 after the shares lost 90 per cent of their value in one year....
...Pharma groups are optimistic about the potential for new weight loss and diabetes drugs known as GLP-1s to treat liver diseases....
...Eli Lilly’s weight-loss drug tirzepatide significantly reduced sleep apnoea problems in a late-stage clinical trial, the pharmaceutical group said on Wednesday, adding to evidence that could encourage more...
...Vertex “is probably going to be one of the fastest-growing top lines outside of the weight-loss drugmakers [Eli] Lilly and Novo [Nordisk],” predicts Debjit Chattopadhyay, a healthcare analyst at Guggenheim...
...Aardvark Therapeutics, a US biotech group developing a weight loss pill, is planning to raise up to $200mn in an initial public offering as early as this summer, propelled by investor hype over anti-obesity...
...Adam Steensberg, chief executive of Zealand Pharma, one of the smaller groups hoping to break into the market, believes consumers need to be offered something different....
...Privately held German pharma group Boehringer Ingelheim and Zealand Pharma’s survodutide treatment had a “statistically significant improvement” for 83 per cent of patients with metabolic dysfunction-associated...
...“Parts of our roof are literally on another farm one kilometre away.” Her neighbours, a group of workers, were now homeless after their less-secure buildings were completely destroyed, she said....
...They include the popular new diabetes and weight-loss drugs Ozempic and Wegovy, made by Novo Nordisk, and Mounjaro and Zepbound made by Eli Lilly....
...More than one in four adults in England are obese, according to the Health Survey for England 2021....
...Viking said as many as 88 per cent of patients who received the drug achieved at least 10 per cent weight loss, compared with just 4 per cent for the placebo group....
...Leqembi slowed cognitive decline by 27 per cent compared with the placebo group in a phase 3 trial....
...The US Centers for Disease Control and Prevention defines a BMI of 30 and over as obese....
...The booming weight loss drug market — which is expected to be worth $100bn by the end of the decade — is dominated by those two rivals....
...One bullish estimate reckons Zepbound and Mounjaro could generate over $50bn in peak annual sales. That compares to Lilly’s total revenues of $28.5bn for the whole of 2022....
...The World Health Organization has identified antimicrobial resistance as one of the top 10 global public health threats....
...And it is just one of many pandemic hangovers that deserve attention....
...“MLD places an enormous emotional and economic burden on families and caregivers — who face substantial wage loss and added expenses each year as the disease progresses — all while dealing with the unquantifiable...
...“It’s clearly very important because this is the first one going to trial....
...The paper highlights how a sharp increase in the number of people living with the impact of neurological conditions is one consequence of rising life expectancy....
...Prostate cancer accounts for almost one-sixth of male cancers, making it the most common form of the disease in more than half the world’s nations....
...This could have a major impact in the US, where more than 40 per cent of the population is obese, according to the US Centers for Disease Control and Prevention....
...Metro added: “Support for the debt refinancing is one of the key pillars to the implementation of the transaction set out in the [Sunday] announcement.”...
...But for most countries you have to go very far out in the climate scenarios to generate an event as severe in terms of loss of life and economic cost as Covid....
International Edition